Buy Vicasol injection 1% ampoules 1%, 1 ml, 10 pcs

Vicasol® [Menadione sodium bisulfite]

Brand Dalkhimpharm

In stock 1770 Items

Available since: 2019-09-19

All payments are SSL encrypted
Full Refund if you haven't received your order
International shipping to the USA, UK and Europe

Clinical Pharmacology

Antihemorrhagic agent. It is a synthetic analogue of vitamin K. It is a cofactor for the synthesis of prothrombin and other blood coagulation factors (VII, IX, X) in the liver, contributes to the normalization of the blood coagulation process.

Indications

Hemorrhagic syndrome associated with hypoprothrombinemia; hypovitaminosis K (including with obstructive jaundice, hepatitis, cirrhosis of the liver, prolonged diarrhea); hemorrhagic disease of the newborn; bleeding after injuries, injuries and surgical interventions; in gynecology as part of complex treatment of dysfunctional uterine bleeding, not associated with organic pathology, in menorrhagia. As a specific antagonist in bleeding associated with the administration of indirect anticoagulants. III trimester of pregnancy (to prevent bleeding in newborns).

Composition

1 ampoule (1 ml) contains 10 mg of menadione sodium bisulfite

Menadione sodium bisulfite is marketed under different brands and generic names, and comes in different dosage forms:

Brand name	Manufacturer	Country	Dosage form
Vicasol	Dalkhimpharm	Russia	ampoules
Vicasol	Pharmstandard	Russia	pills
Vicasol	Ellara	Russia	ampoules

No customer reviews for the moment.

Write your review

Dosage and Administration

Vicasol prescribed by mouth for 15-30 mg per day for adults.

Children under the age of 1 year - 2-5 mg per day, from 1 to 2 years old - 6 mg per day, 3-4 years - 8 mg per day, 5-9 years - 10 mg per day, 10- 14 years - 15 mg per day. Reception frequency - 2-3 times a day.

The maximum daily dose of the drug for newborns - 4 mg.
Duration of treatment is 3-4 days. The course of treatment is repeated after 4 days break.

Adverse reactions

hemolytic anemia;
hyperbilirubinemia;
jaundice, especially in premature babies;
hemolysis in newborns with congenital glucose – 6-phosphate dehydrogenase deficiency.

Carefully:

deficiency of 6-phosphate dehydrogenase;
liver failure;
pregnancy.

Drug interactions

Reduces or blocks the anticoagulant action of neodicoumarin and fenilina. Does not affect the anticoagulant activity of heparin. Simultaneous administration with broad-spectrum antibiotics, quinidine, quinine, high-dose salicylates, antibacterial sulfonamides requires an increase in the dose of vitamin K.

Pregnancy and Lactation

It is used during pregnancy according to indications.

Special instructions

In hemophilia, von Willebrand and Verlhof disease, the drug is ineffective.

When glucose-6-phosphate dehydrogenase is deficient, it can cause hemolysis.

Overdosage

Rarely - hypervitaminosis K, manifested hyperprothrombin- and hyperthrombinemia, hyperbilirubinemia, increased blood clotting, thromboembolism. Symptomatic treatment.

Studies and clinical trials of Menadione sodium bisulfite (Click to expand)